TCOM:NASDAQTrip.com Group Limited Analysis
Data as of 2026-05-04 - not real-time
$52.83
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Trip.com (TCOM) is trading around $52.8, comfortably above its 20‑day SMA of $53.1 but below the 50‑day SMA of $52.2, indicating a flat short‑term bias. The MACD histogram is modestly positive and the RSI sits near 49, suggesting limited momentum and a neutral trend. Support sits at $49.6 while resistance is near $55.7, and the stock has experienced a sharp 30‑day volatility of roughly 25%, with a beta close to 1, implying market‑aligned risk. On the fundamentals side, revenue grew 21% year‑over‑year, gross margins exceed 80%, and the trailing PE is just 7.6, placing the stock well below its DCF‑derived fair value of $172, which translates to a ~45% upside. Cash on hand ($71.9B) dwarfs debt ($31.6B) and the payout ratio is a modest 4.6%, making the 0.57% dividend appear sustainable. However, the company faces heightened regulatory scrutiny, highlighted by multiple securities‑fraud class‑action filings alleging antitrust misstatements, which have contributed to a recent 17% price drop.
Overall, the valuation metrics and cash strength support a buy view, but the ongoing legal risk and high volatility advise caution in the near term.
Overall, the valuation metrics and cash strength support a buy view, but the ongoing legal risk and high volatility advise caution in the near term.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near support with limited upside in the next weeks
- Neutral technical indicators (RSI, MACD) and high short‑term volatility
- Pending securities‑fraud litigation creating near‑term uncertainty
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong revenue growth and high operating margins
- Substantial upside to DCF fair value and low PE multiple
- Sustainable dividend and ample cash cushion
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Long‑term undervaluation with ~45% upside to target price
- Robust cash generation and low payout ratio supporting dividend growth
- Potential resolution of regulatory issues and continued market share expansion in travel services
Key Metrics & Analysis
Financial Health
Revenue Growth20.80%
Profit Margin53.35%
P/E Ratio7.6
ROE21.13%
ROA3.87%
Debt/Equity18.32
P/B Ratio1.4
Op. Cash Flow$14.4B
Free Cash Flow$2.2B
Technical Analysis
TrendNeutral
RSI48.9
Support$49.62
Resistance$55.70
MA 20$53.12
MA 50$52.23
MA 200$64.43
MACDBullish
VolumeStable
Fear & Greed Index88.27
Valuation
Fair Value$172.33
Target Price$76.55
Upside/Downside44.91%
GradeUndervalued
TypeGrowth
Dividend Yield0.57%
Risk Assessment
Beta0.98
Volatility24.90%
Sector RiskHigh
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.